ペプチドリームの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/03/18 | 5,150 | 5,200 | 5,110 | 5,160 | +50 | +1% | 481,200 |
2021/03/17 | 4,990 | 5,130 | 4,960 | 5,110 | +115 | +2.3% | 562,900 |
2021/03/16 | 4,905 | 5,010 | 4,870 | 4,995 | +80 | +1.6% | 488,500 |
2021/03/15 | 4,960 | 4,980 | 4,830 | 4,915 | -35 | -0.7% | 473,500 |
2021/03/12 | 4,865 | 4,975 | 4,855 | 4,950 | +55 | +1.1% | 470,800 |
2021/03/11 | 4,915 | 4,915 | 4,820 | 4,895 | -15 | -0.3% | 429,900 |
2021/03/10 | 4,875 | 4,915 | 4,815 | 4,910 | +70 | +1.4% | 551,300 |
2021/03/09 | 4,750 | 4,880 | 4,675 | 4,840 | +20 | +0.4% | 599,400 |
2021/03/08 | 4,955 | 4,980 | 4,810 | 4,820 | -65 | -1.3% | 374,300 |
2021/03/05 | 4,900 | 4,910 | 4,755 | 4,885 | -25 | -0.5% | 605,900 |
2021/03/04 | 5,000 | 5,000 | 4,855 | 4,910 | -170 | -3.3% | 568,800 |
2021/03/03 | 5,090 | 5,120 | 5,020 | 5,080 | +30 | +0.6% | 421,300 |
2021/03/02 | 5,140 | 5,160 | 5,030 | 5,050 | -20 | -0.4% | 457,900 |
2021/03/01 | 5,060 | 5,120 | 5,030 | 5,070 | ±0 | ±0% | 647,400 |
2021/02/26 | 5,110 | 5,170 | 5,050 | 5,070 | -140 | -2.7% | 726,900 |
2021/02/25 | 5,240 | 5,260 | 5,160 | 5,210 | +30 | +0.6% | 511,600 |
2021/02/24 | 5,340 | 5,360 | 5,180 | 5,180 | -240 | -4.4% | 660,700 |
2021/02/22 | 5,450 | 5,560 | 5,420 | 5,420 | +20 | +0.4% | 639,500 |
2021/02/19 | 5,450 | 5,480 | 5,360 | 5,400 | -10 | -0.2% | 410,900 |
2021/02/18 | 5,510 | 5,540 | 5,360 | 5,410 | ±0 | ±0% | 618,500 |
2021/02/17 | 5,500 | 5,500 | 5,330 | 5,410 | -90 | -1.6% | 671,200 |
2021/02/16 | 5,700 | 5,700 | 5,460 | 5,500 | -170 | -3% | 761,000 |
2021/02/15 | 5,860 | 5,910 | 5,590 | 5,670 | -150 | -2.6% | 754,700 |
2021/02/12 | 5,900 | 6,030 | 5,740 | 5,820 | -560 | -8.8% | 1,213,000 |
2021/02/10 | 6,320 | 6,410 | 6,220 | 6,380 | +40 | +0.6% | 458,600 |
2021/02/09 | 6,510 | 6,510 | 6,300 | 6,340 | -170 | -2.6% | 630,200 |
2021/02/08 | 6,460 | 6,540 | 6,400 | 6,510 | +70 | +1.1% | 467,900 |
2021/02/05 | 6,260 | 6,470 | 6,240 | 6,440 | +160 | +2.5% | 510,700 |
2021/02/04 | 6,310 | 6,320 | 6,250 | 6,280 | -90 | -1.4% | 387,500 |
2021/02/03 | 6,300 | 6,370 | 6,210 | 6,370 | +30 | +0.5% | 408,500 |
2021/02/02 | 6,350 | 6,380 | 6,280 | 6,340 | ±0 | ±0% | 548,000 |
2021/02/01 | 6,140 | 6,350 | 6,110 | 6,340 | +230 | +3.8% | 614,900 |
2021/01/29 | 6,080 | 6,150 | 6,040 | 6,110 | +70 | +1.2% | 839,600 |
2021/01/28 | 5,770 | 6,070 | 5,760 | 6,040 | +180 | +3.1% | 919,100 |
2021/01/27 | 5,760 | 5,870 | 5,750 | 5,860 | +100 | +1.7% | 297,900 |
2021/01/26 | 5,910 | 5,910 | 5,710 | 5,760 | -150 | -2.5% | 428,900 |
2021/01/25 | 5,790 | 5,930 | 5,780 | 5,910 | +80 | +1.4% | 248,600 |
2021/01/22 | 5,820 | 5,860 | 5,760 | 5,830 | -90 | -1.5% | 365,600 |
2021/01/21 | 6,000 | 6,050 | 5,870 | 5,920 | -70 | -1.2% | 474,200 |
2021/01/20 | 5,880 | 6,050 | 5,840 | 5,990 | +160 | +2.7% | 793,900 |
2021/01/19 | 5,800 | 5,860 | 5,760 | 5,830 | +70 | +1.2% | 436,900 |
2021/01/18 | 5,760 | 5,830 | 5,730 | 5,760 | -10 | -0.2% | 277,100 |
2021/01/15 | 5,750 | 5,790 | 5,710 | 5,770 | ±0 | ±0% | 292,600 |
2021/01/14 | 5,730 | 5,810 | 5,720 | 5,770 | -30 | -0.5% | 380,000 |
2021/01/13 | 5,780 | 5,810 | 5,670 | 5,800 | -30 | -0.5% | 393,800 |
2021/01/12 | 5,840 | 5,880 | 5,790 | 5,830 | -10 | -0.2% | 401,500 |
2021/01/08 | 5,800 | 5,840 | 5,750 | 5,840 | +100 | +1.7% | 548,500 |
2021/01/07 | 5,770 | 5,830 | 5,730 | 5,740 | +30 | +0.5% | 538,000 |
2021/01/06 | 5,600 | 5,740 | 5,520 | 5,710 | -20 | -0.3% | 541,000 |
2021/01/05 | 5,470 | 5,880 | 5,460 | 5,730 | +490 | +9.4% | 1,406,700 |
1001~
1050
件表示中 / 2898件
類似銘柄と比較する
現在ご覧いただいている「ペプチド」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
ペプチド | 189,600円 | +5.0% | +1.5% | 0.00% | 16.27倍 | 4.33倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
サワイGHD | 195,200円 | +4.0% | +25.4% | 2.72% | 8.54倍 | 1.12倍 |
|
ジェネリック(後発)薬大手メーカー。21年春に沢井製薬が持株会社化。大型買収で米国本格展開 |
日本新薬 | 358,100円 | +7.9% | +8.9% | 3.46% | 7.66倍 | 1.03倍 |
|
医家向け医薬品主体、自社創薬は泌尿器科、血液内科、難病・希少疾患に集中。機能食品も育成 |
科研薬 | 405,800円 | +30.5% | +111.0% | 4.68% | 11.44倍 | 0.99倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
キッセイ薬 | 376,000円 | +14.5% | -2.3% | 2.39% | 13.75倍 | 0.73倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
市場注目の銘柄
チャート関連のコラム